Literature DB >> 22210120

The routes to orphan drug designation--our recent experience at the FDA.

Daniel Lev, Chandana Thorat, Ian Phillips, Mathew Thomas, Menfo A Imoisili.   

Abstract

Mesh:

Year:  2011        PMID: 22210120     DOI: 10.1016/j.drudis.2011.12.014

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  1 in total

1.  The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislation.

Authors:  Pedro Franco; Nuria Porta; John D Holliday; Peter Willett
Journal:  J Cheminform       Date:  2014-02-01       Impact factor: 5.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.